Top compounds associated with response to ZNF444


Feature Type Standardized
Nominal ANOVA
mRNA nelarabine CTRPv2 pan-cancer AAC 0.23 4e-09
mRNA ABT-263 CTRPv2 pan-cancer AAC 0.18 4e-07
mRNA UNC0638:navitoclax (1:1 mol/mol) CTRPv2 pan-cancer AAC 0.17 6e-06
mRNA navitoclax:piperlongumine (1:1 mol/mol) CTRPv2 pan-cancer AAC 0.16 7e-06
mRNA tretinoin:navitoclax (4:1 mol/mol) CTRPv2 pan-cancer AAC 0.16 1e-05
mRNA Docetaxel gCSI pan-cancer AAC -0.25 1e-05
mRNA paclitaxel gCSI pan-cancer AAC -0.24 2e-05
mRNA BRD-A02303741:navitoclax (2:1 mol/mol) CTRPv2 pan-cancer AAC 0.15 3e-05
mRNA PD-0325901 GDSC1000 pan-cancer AAC -0.14 3e-05
mRNA WZ3105 GDSC1000 pan-cancer AAC 0.13 4e-05
Download CSV